You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 18, 2024

Investigational Drug Information for Islatravir

✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Islatravir?

Islatravir is an investigational drug.

There have been 23 clinical trials for Islatravir. The most recent clinical trial was a Phase 1 trial, which was initiated on February 28th 2020.

The most common disease conditions in clinical trials are HIV Infections, Infections, and Infection. The leading clinical trial sponsors are Merck Sharp & Dohme Corp., Merck Sharp & Dohme LLC, and Gilead Sciences.

There are seven US patents protecting this investigational drug and two hundred and seventy-six international patents.

Recent Clinical Trials for Islatravir
A Study of Doravirine/Islatravir (DOR/ISL, MK-8591A) for the Treatment of Human Immunodeficiency Virus 1 (HIV-1) Infection in Participants Who Previously Received DOR/ISL (MK-8591A-054)Merck Sharp & Dohme LLCPhase 3
DOR/ISL in HIV-1 Antiretroviral Treatment-naïve Participants (MK-8591A-053)Merck Sharp & Dohme LLCPhase 3
A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-052)Merck Sharp & Dohme LLCPhase 3

See all Islatravir clinical trials

Clinical Trial Summary for Islatravir

Top disease conditions for Islatravir
Top clinical trial sponsors for Islatravir

See all Islatravir clinical trials

US Patents for Islatravir

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Islatravir ⤷  Sign Up Therapeutic compounds Gilead Sciences, Inc. (Foster City, CA) ⤷  Sign Up
Islatravir ⤷  Sign Up Substituted spiropyrido[1,2-a]pyrazine derivative and medicinal use thereof as HIV integrase inhibitor JAPAN TOBACCO INC. (Tokyo, JP) ⤷  Sign Up
Islatravir ⤷  Sign Up Macroheterocyclic nucleoside derivatives and their analogues, production and use thereof ⤷  Sign Up
Islatravir ⤷  Sign Up Antiviral prodrugs of tenofovir Merck Sharp & Dohme Corp. (Rahway, NJ) Idenix Pharmaceuticals LLC. (Cambridge, MA) ⤷  Sign Up
Islatravir ⤷  Sign Up Therapeutic compounds Gilead Sciences, Inc. (Foster City, CA) ⤷  Sign Up
Islatravir ⤷  Sign Up Solid forms of an HIV capsid inhibitor Gilead Sciences, Inc. ⤷  Sign Up
Islatravir ⤷  Sign Up Potent chimeric NRTI-NNRTI bifunctional inhibitors of HIV-1 reverse transcriptase Yale University (New Haven, CT) University of Cape Town (Cape Town, ZA) ⤷  Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Islatravir

Drugname Country Document Number Estimated Expiration Related US Patent
Islatravir Argentina AR109364 2036-08-19 ⤷  Sign Up
Islatravir Argentina AR115865 2036-08-19 ⤷  Sign Up
Islatravir Argentina AR117709 2036-08-19 ⤷  Sign Up
Islatravir Australia AU2017312102 2036-08-19 ⤷  Sign Up
Islatravir Australia AU2020202331 2036-08-19 ⤷  Sign Up
Islatravir Australia AU2021221855 2036-08-19 ⤷  Sign Up
Islatravir Brazil BR112018071678 2036-08-19 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.